ZHIHU-W (02390) spent approximately $106,800 on July 31 to repurchase 97,800 shares.
Zhihu-W (02390) announced that on July 31, 2026, the company will spend approximately $106,800 to repurchase 97,800 shares, with a repurchase price ranging from $1.07 to $1.0967 per share.
ZHIHU-W (02390) announced that on July 31, 2026, the company will spend approximately $106,800 to repurchase 97,800 shares, with a repurchase price of $1.07 to $1.0967 per share.
Related Articles
BASICSEMI (09971): The period for stabilizing prices has ended, and no actions have been taken to stabilize prices, while the over-allotment option has also lapsed.
INSILICO (03696) and Hengtai Biotech have jointly developed the blood-brain barrier penetrating NLRP3 inhibitor ISM8969/HT-001, which has received approval for clinical trials from the NMPA.
CHIHO ENV(00976): No information regarding the transaction has yet been obtained from the receiver.
BASICSEMI (09971): The period for stabilizing prices has ended, and no actions have been taken to stabilize prices, while the over-allotment option has also lapsed.
INSILICO (03696) and Hengtai Biotech have jointly developed the blood-brain barrier penetrating NLRP3 inhibitor ISM8969/HT-001, which has received approval for clinical trials from the NMPA.
CHIHO ENV(00976): No information regarding the transaction has yet been obtained from the receiver.
RECOMMEND
